Prime Medicine

About:

Prime Medicine operates as a biotechnology company that delivers the promise of gene editing using Prime Editing.

Website: https://www.primemedicine.com

Top Investors: F-Prime Capital, ARCH Venture Partners, Bristol-Myers Squibb, Cormorant Asset Management, Google Ventures

Description:

Prime Medicine is a biotechnology company founded to deliver on the promise of Prime Editing, a versatile gene editing technology that can truly "search and replace" to restore normal genetic function and address the fundamental causes of disease.

Total Funding Amount:

$385M

Estimated Revenue Range:

$10M to $50M

Headquarters Location:

Cambridge, Massachusetts, United States

Founded Date:

2019-01-01

Contact Email:

info(AT)primemedicine.com

Hub Tags:

Exited Unicorn

Founders:

Andrew Anzalone, David R. Liu

Number of Employees:

101-250

Last Funding Date:

2024-09-30

IPO Status:

Public

© 2025 bioDAO.ai